Liposomal encapsulation is a nascent technology in the supplements space, and proving liposomes were created requires a battery of technical, expensive tests.
The formulation of TSI Group’s PeakATP has made it 46% more stable at 12 months and 59% more stable at 6 months in aseptic hot-fill processed beverages.
Vitaquest International's new facility comes with fluidized bed process technologies enabling particle and powder engineering for foods and dietary supplements.
Oral solids remain the preferred route of drug delivery due to their cost-effectiveness, ease of manufacturing, and patient-friendly dose form options.